Medical Care
Global Endocrine Disruptor Assessment Market Research Report 2025
- Apr 16, 25
- ID: 195536
- Pages: 84
- Figures: 85
- Views: 39
The global market for Endocrine Disruptor Assessment was valued at US$ 198 million in the year 2024 and is projected to reach a revised size of US$ 305 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Endocrine Disruptor Assessment is the process of evaluating chemicals or substances for their potential to interfere with the endocrine system, which regulates hormones in living organisms. This assessment involves a combination of in vitro (laboratory-based), in vivo (animal-based), and computational methods to identify substances that may mimic, block, or alter hormonal functions, leading to adverse health effects such as reproductive issues, developmental disorders, or metabolic imbalances.
North American market for Endocrine Disruptor Assessment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Endocrine Disruptor Assessment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Endocrine Disruptor Assessment in Environmental Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Endocrine Disruptor Assessment include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptor Assessment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptor Assessment.
The Endocrine Disruptor Assessment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrine Disruptor Assessment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptor Assessment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray
Segment by Type
In Vitro (Cell-based) Testing
In Vivo (Animal) Testing
In Silico (Computational) Modeling
Others
Segment by Application
Environmental Monitoring
Food Safety
Cosmetics and Personal Care Products
Public Health and Disease Prevention
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptor Assessment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Endocrine Disruptor Assessment is the process of evaluating chemicals or substances for their potential to interfere with the endocrine system, which regulates hormones in living organisms. This assessment involves a combination of in vitro (laboratory-based), in vivo (animal-based), and computational methods to identify substances that may mimic, block, or alter hormonal functions, leading to adverse health effects such as reproductive issues, developmental disorders, or metabolic imbalances.
North American market for Endocrine Disruptor Assessment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Endocrine Disruptor Assessment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Endocrine Disruptor Assessment in Environmental Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Endocrine Disruptor Assessment include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptor Assessment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptor Assessment.
The Endocrine Disruptor Assessment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrine Disruptor Assessment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptor Assessment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray
Segment by Type
In Vitro (Cell-based) Testing
In Vivo (Animal) Testing
In Silico (Computational) Modeling
Others
Segment by Application
Environmental Monitoring
Food Safety
Cosmetics and Personal Care Products
Public Health and Disease Prevention
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptor Assessment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptor Assessment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro (Cell-based) Testing
1.2.3 In Vivo (Animal) Testing
1.2.4 In Silico (Computational) Modeling
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrine Disruptor Assessment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Environmental Monitoring
1.3.3 Food Safety
1.3.4 Cosmetics and Personal Care Products
1.3.5 Public Health and Disease Prevention
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptor Assessment Market Perspective (2020-2031)
2.2 Global Endocrine Disruptor Assessment Growth Trends by Region
2.2.1 Global Endocrine Disruptor Assessment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocrine Disruptor Assessment Historic Market Size by Region (2020-2025)
2.2.3 Endocrine Disruptor Assessment Forecasted Market Size by Region (2026-2031)
2.3 Endocrine Disruptor Assessment Market Dynamics
2.3.1 Endocrine Disruptor Assessment Industry Trends
2.3.2 Endocrine Disruptor Assessment Market Drivers
2.3.3 Endocrine Disruptor Assessment Market Challenges
2.3.4 Endocrine Disruptor Assessment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptor Assessment Players by Revenue
3.1.1 Global Top Endocrine Disruptor Assessment Players by Revenue (2020-2025)
3.1.2 Global Endocrine Disruptor Assessment Revenue Market Share by Players (2020-2025)
3.2 Global Top Endocrine Disruptor Assessment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptor Assessment Revenue
3.4 Global Endocrine Disruptor Assessment Market Concentration Ratio
3.4.1 Global Endocrine Disruptor Assessment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptor Assessment Revenue in 2024
3.5 Global Key Players of Endocrine Disruptor Assessment Head office and Area Served
3.6 Global Key Players of Endocrine Disruptor Assessment, Product and Application
3.7 Global Key Players of Endocrine Disruptor Assessment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptor Assessment Breakdown Data by Type
4.1 Global Endocrine Disruptor Assessment Historic Market Size by Type (2020-2025)
4.2 Global Endocrine Disruptor Assessment Forecasted Market Size by Type (2026-2031)
5 Endocrine Disruptor Assessment Breakdown Data by Application
5.1 Global Endocrine Disruptor Assessment Historic Market Size by Application (2020-2025)
5.2 Global Endocrine Disruptor Assessment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocrine Disruptor Assessment Market Size (2020-2031)
6.2 North America Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocrine Disruptor Assessment Market Size by Country (2020-2025)
6.4 North America Endocrine Disruptor Assessment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptor Assessment Market Size (2020-2031)
7.2 Europe Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocrine Disruptor Assessment Market Size by Country (2020-2025)
7.4 Europe Endocrine Disruptor Assessment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptor Assessment Market Size (2020-2031)
8.2 Asia-Pacific Endocrine Disruptor Assessment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruptor Assessment Market Size (2020-2031)
9.2 Latin America Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocrine Disruptor Assessment Market Size by Country (2020-2025)
9.4 Latin America Endocrine Disruptor Assessment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptor Assessment Market Size (2020-2031)
10.2 Middle East & Africa Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Endocrine Disruptor Assessment Introduction
11.1.4 Charles River Laboratories Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Endocrine Disruptor Assessment Introduction
11.2.4 Labcorp Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Endocrine Disruptor Assessment Introduction
11.3.4 Eurofins Scientific Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Endocrine Disruptor Assessment Introduction
11.4.4 PerkinElmer Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.4.5 PerkinElmer Recent Development
11.5 Intertek
11.5.1 Intertek Company Details
11.5.2 Intertek Business Overview
11.5.3 Intertek Endocrine Disruptor Assessment Introduction
11.5.4 Intertek Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.5.5 Intertek Recent Development
11.6 Smithers
11.6.1 Smithers Company Details
11.6.2 Smithers Business Overview
11.6.3 Smithers Endocrine Disruptor Assessment Introduction
11.6.4 Smithers Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.6.5 Smithers Recent Development
11.7 LAUS
11.7.1 LAUS Company Details
11.7.2 LAUS Business Overview
11.7.3 LAUS Endocrine Disruptor Assessment Introduction
11.7.4 LAUS Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.7.5 LAUS Recent Development
11.8 Xenometrix
11.8.1 Xenometrix Company Details
11.8.2 Xenometrix Business Overview
11.8.3 Xenometrix Endocrine Disruptor Assessment Introduction
11.8.4 Xenometrix Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.8.5 Xenometrix Recent Development
11.9 ToxStrategies
11.9.1 ToxStrategies Company Details
11.9.2 ToxStrategies Business Overview
11.9.3 ToxStrategies Endocrine Disruptor Assessment Introduction
11.9.4 ToxStrategies Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.9.5 ToxStrategies Recent Development
11.10 Fera Science
11.10.1 Fera Science Company Details
11.10.2 Fera Science Business Overview
11.10.3 Fera Science Endocrine Disruptor Assessment Introduction
11.10.4 Fera Science Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.10.5 Fera Science Recent Development
11.11 Compliance Services International
11.11.1 Compliance Services International Company Details
11.11.2 Compliance Services International Business Overview
11.11.3 Compliance Services International Endocrine Disruptor Assessment Introduction
11.11.4 Compliance Services International Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.11.5 Compliance Services International Recent Development
11.12 Staphyt
11.12.1 Staphyt Company Details
11.12.2 Staphyt Business Overview
11.12.3 Staphyt Endocrine Disruptor Assessment Introduction
11.12.4 Staphyt Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.12.5 Staphyt Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Details
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Endocrine Disruptor Assessment Introduction
11.13.4 Creative Proteomics Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.13.5 Creative Proteomics Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptor Assessment Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptor Assessment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro (Cell-based) Testing
1.2.3 In Vivo (Animal) Testing
1.2.4 In Silico (Computational) Modeling
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrine Disruptor Assessment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Environmental Monitoring
1.3.3 Food Safety
1.3.4 Cosmetics and Personal Care Products
1.3.5 Public Health and Disease Prevention
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptor Assessment Market Perspective (2020-2031)
2.2 Global Endocrine Disruptor Assessment Growth Trends by Region
2.2.1 Global Endocrine Disruptor Assessment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocrine Disruptor Assessment Historic Market Size by Region (2020-2025)
2.2.3 Endocrine Disruptor Assessment Forecasted Market Size by Region (2026-2031)
2.3 Endocrine Disruptor Assessment Market Dynamics
2.3.1 Endocrine Disruptor Assessment Industry Trends
2.3.2 Endocrine Disruptor Assessment Market Drivers
2.3.3 Endocrine Disruptor Assessment Market Challenges
2.3.4 Endocrine Disruptor Assessment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptor Assessment Players by Revenue
3.1.1 Global Top Endocrine Disruptor Assessment Players by Revenue (2020-2025)
3.1.2 Global Endocrine Disruptor Assessment Revenue Market Share by Players (2020-2025)
3.2 Global Top Endocrine Disruptor Assessment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptor Assessment Revenue
3.4 Global Endocrine Disruptor Assessment Market Concentration Ratio
3.4.1 Global Endocrine Disruptor Assessment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptor Assessment Revenue in 2024
3.5 Global Key Players of Endocrine Disruptor Assessment Head office and Area Served
3.6 Global Key Players of Endocrine Disruptor Assessment, Product and Application
3.7 Global Key Players of Endocrine Disruptor Assessment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptor Assessment Breakdown Data by Type
4.1 Global Endocrine Disruptor Assessment Historic Market Size by Type (2020-2025)
4.2 Global Endocrine Disruptor Assessment Forecasted Market Size by Type (2026-2031)
5 Endocrine Disruptor Assessment Breakdown Data by Application
5.1 Global Endocrine Disruptor Assessment Historic Market Size by Application (2020-2025)
5.2 Global Endocrine Disruptor Assessment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocrine Disruptor Assessment Market Size (2020-2031)
6.2 North America Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocrine Disruptor Assessment Market Size by Country (2020-2025)
6.4 North America Endocrine Disruptor Assessment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptor Assessment Market Size (2020-2031)
7.2 Europe Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocrine Disruptor Assessment Market Size by Country (2020-2025)
7.4 Europe Endocrine Disruptor Assessment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptor Assessment Market Size (2020-2031)
8.2 Asia-Pacific Endocrine Disruptor Assessment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruptor Assessment Market Size (2020-2031)
9.2 Latin America Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocrine Disruptor Assessment Market Size by Country (2020-2025)
9.4 Latin America Endocrine Disruptor Assessment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptor Assessment Market Size (2020-2031)
10.2 Middle East & Africa Endocrine Disruptor Assessment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Endocrine Disruptor Assessment Introduction
11.1.4 Charles River Laboratories Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Endocrine Disruptor Assessment Introduction
11.2.4 Labcorp Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Endocrine Disruptor Assessment Introduction
11.3.4 Eurofins Scientific Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Endocrine Disruptor Assessment Introduction
11.4.4 PerkinElmer Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.4.5 PerkinElmer Recent Development
11.5 Intertek
11.5.1 Intertek Company Details
11.5.2 Intertek Business Overview
11.5.3 Intertek Endocrine Disruptor Assessment Introduction
11.5.4 Intertek Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.5.5 Intertek Recent Development
11.6 Smithers
11.6.1 Smithers Company Details
11.6.2 Smithers Business Overview
11.6.3 Smithers Endocrine Disruptor Assessment Introduction
11.6.4 Smithers Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.6.5 Smithers Recent Development
11.7 LAUS
11.7.1 LAUS Company Details
11.7.2 LAUS Business Overview
11.7.3 LAUS Endocrine Disruptor Assessment Introduction
11.7.4 LAUS Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.7.5 LAUS Recent Development
11.8 Xenometrix
11.8.1 Xenometrix Company Details
11.8.2 Xenometrix Business Overview
11.8.3 Xenometrix Endocrine Disruptor Assessment Introduction
11.8.4 Xenometrix Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.8.5 Xenometrix Recent Development
11.9 ToxStrategies
11.9.1 ToxStrategies Company Details
11.9.2 ToxStrategies Business Overview
11.9.3 ToxStrategies Endocrine Disruptor Assessment Introduction
11.9.4 ToxStrategies Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.9.5 ToxStrategies Recent Development
11.10 Fera Science
11.10.1 Fera Science Company Details
11.10.2 Fera Science Business Overview
11.10.3 Fera Science Endocrine Disruptor Assessment Introduction
11.10.4 Fera Science Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.10.5 Fera Science Recent Development
11.11 Compliance Services International
11.11.1 Compliance Services International Company Details
11.11.2 Compliance Services International Business Overview
11.11.3 Compliance Services International Endocrine Disruptor Assessment Introduction
11.11.4 Compliance Services International Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.11.5 Compliance Services International Recent Development
11.12 Staphyt
11.12.1 Staphyt Company Details
11.12.2 Staphyt Business Overview
11.12.3 Staphyt Endocrine Disruptor Assessment Introduction
11.12.4 Staphyt Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.12.5 Staphyt Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Details
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Endocrine Disruptor Assessment Introduction
11.13.4 Creative Proteomics Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.13.5 Creative Proteomics Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptor Assessment Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptor Assessment Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Endocrine Disruptor Assessment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vitro (Cell-based) Testing
Table 3. Key Players of In Vivo (Animal) Testing
Table 4. Key Players of In Silico (Computational) Modeling
Table 5. Key Players of Others
Table 6. Global Endocrine Disruptor Assessment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Endocrine Disruptor Assessment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Endocrine Disruptor Assessment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Endocrine Disruptor Assessment Market Share by Region (2020-2025)
Table 10. Global Endocrine Disruptor Assessment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Endocrine Disruptor Assessment Market Share by Region (2026-2031)
Table 12. Endocrine Disruptor Assessment Market Trends
Table 13. Endocrine Disruptor Assessment Market Drivers
Table 14. Endocrine Disruptor Assessment Market Challenges
Table 15. Endocrine Disruptor Assessment Market Restraints
Table 16. Global Endocrine Disruptor Assessment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Endocrine Disruptor Assessment Market Share by Players (2020-2025)
Table 18. Global Top Endocrine Disruptor Assessment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptor Assessment as of 2024)
Table 19. Ranking of Global Top Endocrine Disruptor Assessment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Endocrine Disruptor Assessment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Endocrine Disruptor Assessment, Headquarters and Area Served
Table 22. Global Key Players of Endocrine Disruptor Assessment, Product and Application
Table 23. Global Key Players of Endocrine Disruptor Assessment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endocrine Disruptor Assessment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Endocrine Disruptor Assessment Revenue Market Share by Type (2020-2025)
Table 27. Global Endocrine Disruptor Assessment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Endocrine Disruptor Assessment Revenue Market Share by Type (2026-2031)
Table 29. Global Endocrine Disruptor Assessment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Endocrine Disruptor Assessment Revenue Market Share by Application (2020-2025)
Table 31. Global Endocrine Disruptor Assessment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Endocrine Disruptor Assessment Revenue Market Share by Application (2026-2031)
Table 33. North America Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Endocrine Disruptor Assessment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Laboratories Company Details
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories Endocrine Disruptor Assessment Product
Table 51. Charles River Laboratories Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 52. Charles River Laboratories Recent Development
Table 53. Labcorp Company Details
Table 54. Labcorp Business Overview
Table 55. Labcorp Endocrine Disruptor Assessment Product
Table 56. Labcorp Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 57. Labcorp Recent Development
Table 58. Eurofins Scientific Company Details
Table 59. Eurofins Scientific Business Overview
Table 60. Eurofins Scientific Endocrine Disruptor Assessment Product
Table 61. Eurofins Scientific Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 62. Eurofins Scientific Recent Development
Table 63. PerkinElmer Company Details
Table 64. PerkinElmer Business Overview
Table 65. PerkinElmer Endocrine Disruptor Assessment Product
Table 66. PerkinElmer Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 67. PerkinElmer Recent Development
Table 68. Intertek Company Details
Table 69. Intertek Business Overview
Table 70. Intertek Endocrine Disruptor Assessment Product
Table 71. Intertek Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 72. Intertek Recent Development
Table 73. Smithers Company Details
Table 74. Smithers Business Overview
Table 75. Smithers Endocrine Disruptor Assessment Product
Table 76. Smithers Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 77. Smithers Recent Development
Table 78. LAUS Company Details
Table 79. LAUS Business Overview
Table 80. LAUS Endocrine Disruptor Assessment Product
Table 81. LAUS Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 82. LAUS Recent Development
Table 83. Xenometrix Company Details
Table 84. Xenometrix Business Overview
Table 85. Xenometrix Endocrine Disruptor Assessment Product
Table 86. Xenometrix Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 87. Xenometrix Recent Development
Table 88. ToxStrategies Company Details
Table 89. ToxStrategies Business Overview
Table 90. ToxStrategies Endocrine Disruptor Assessment Product
Table 91. ToxStrategies Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 92. ToxStrategies Recent Development
Table 93. Fera Science Company Details
Table 94. Fera Science Business Overview
Table 95. Fera Science Endocrine Disruptor Assessment Product
Table 96. Fera Science Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 97. Fera Science Recent Development
Table 98. Compliance Services International Company Details
Table 99. Compliance Services International Business Overview
Table 100. Compliance Services International Endocrine Disruptor Assessment Product
Table 101. Compliance Services International Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 102. Compliance Services International Recent Development
Table 103. Staphyt Company Details
Table 104. Staphyt Business Overview
Table 105. Staphyt Endocrine Disruptor Assessment Product
Table 106. Staphyt Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 107. Staphyt Recent Development
Table 108. Creative Proteomics Company Details
Table 109. Creative Proteomics Business Overview
Table 110. Creative Proteomics Endocrine Disruptor Assessment Product
Table 111. Creative Proteomics Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 112. Creative Proteomics Recent Development
Table 113. Creative Bioarray Company Details
Table 114. Creative Bioarray Business Overview
Table 115. Creative Bioarray Endocrine Disruptor Assessment Product
Table 116. Creative Bioarray Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 117. Creative Bioarray Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Endocrine Disruptor Assessment Picture
Figure 2. Global Endocrine Disruptor Assessment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocrine Disruptor Assessment Market Share by Type: 2024 VS 2031
Figure 4. In Vitro (Cell-based) Testing Features
Figure 5. In Vivo (Animal) Testing Features
Figure 6. In Silico (Computational) Modeling Features
Figure 7. Others Features
Figure 8. Global Endocrine Disruptor Assessment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Endocrine Disruptor Assessment Market Share by Application: 2024 VS 2031
Figure 10. Environmental Monitoring Case Studies
Figure 11. Food Safety Case Studies
Figure 12. Cosmetics and Personal Care Products Case Studies
Figure 13. Public Health and Disease Prevention Case Studies
Figure 14. Others Case Studies
Figure 15. Endocrine Disruptor Assessment Report Years Considered
Figure 16. Global Endocrine Disruptor Assessment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Endocrine Disruptor Assessment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Endocrine Disruptor Assessment Market Share by Region: 2024 VS 2031
Figure 19. Global Endocrine Disruptor Assessment Market Share by Players in 2024
Figure 20. Global Endocrine Disruptor Assessment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Endocrine Disruptor Assessment Revenue in 2024
Figure 22. North America Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 24. United States Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 28. Germany Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Endocrine Disruptor Assessment Market Share by Region (2020-2031)
Figure 36. China Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 44. Mexico Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 48. Turkey Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 52. Labcorp Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 53. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 54. PerkinElmer Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 55. Intertek Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 56. Smithers Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 57. LAUS Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 58. Xenometrix Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 59. ToxStrategies Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 60. Fera Science Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 61. Compliance Services International Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 62. Staphyt Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 63. Creative Proteomics Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 64. Creative Bioarray Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Endocrine Disruptor Assessment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vitro (Cell-based) Testing
Table 3. Key Players of In Vivo (Animal) Testing
Table 4. Key Players of In Silico (Computational) Modeling
Table 5. Key Players of Others
Table 6. Global Endocrine Disruptor Assessment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Endocrine Disruptor Assessment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Endocrine Disruptor Assessment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Endocrine Disruptor Assessment Market Share by Region (2020-2025)
Table 10. Global Endocrine Disruptor Assessment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Endocrine Disruptor Assessment Market Share by Region (2026-2031)
Table 12. Endocrine Disruptor Assessment Market Trends
Table 13. Endocrine Disruptor Assessment Market Drivers
Table 14. Endocrine Disruptor Assessment Market Challenges
Table 15. Endocrine Disruptor Assessment Market Restraints
Table 16. Global Endocrine Disruptor Assessment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Endocrine Disruptor Assessment Market Share by Players (2020-2025)
Table 18. Global Top Endocrine Disruptor Assessment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptor Assessment as of 2024)
Table 19. Ranking of Global Top Endocrine Disruptor Assessment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Endocrine Disruptor Assessment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Endocrine Disruptor Assessment, Headquarters and Area Served
Table 22. Global Key Players of Endocrine Disruptor Assessment, Product and Application
Table 23. Global Key Players of Endocrine Disruptor Assessment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endocrine Disruptor Assessment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Endocrine Disruptor Assessment Revenue Market Share by Type (2020-2025)
Table 27. Global Endocrine Disruptor Assessment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Endocrine Disruptor Assessment Revenue Market Share by Type (2026-2031)
Table 29. Global Endocrine Disruptor Assessment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Endocrine Disruptor Assessment Revenue Market Share by Application (2020-2025)
Table 31. Global Endocrine Disruptor Assessment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Endocrine Disruptor Assessment Revenue Market Share by Application (2026-2031)
Table 33. North America Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Endocrine Disruptor Assessment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Endocrine Disruptor Assessment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Endocrine Disruptor Assessment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Endocrine Disruptor Assessment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Laboratories Company Details
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories Endocrine Disruptor Assessment Product
Table 51. Charles River Laboratories Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 52. Charles River Laboratories Recent Development
Table 53. Labcorp Company Details
Table 54. Labcorp Business Overview
Table 55. Labcorp Endocrine Disruptor Assessment Product
Table 56. Labcorp Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 57. Labcorp Recent Development
Table 58. Eurofins Scientific Company Details
Table 59. Eurofins Scientific Business Overview
Table 60. Eurofins Scientific Endocrine Disruptor Assessment Product
Table 61. Eurofins Scientific Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 62. Eurofins Scientific Recent Development
Table 63. PerkinElmer Company Details
Table 64. PerkinElmer Business Overview
Table 65. PerkinElmer Endocrine Disruptor Assessment Product
Table 66. PerkinElmer Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 67. PerkinElmer Recent Development
Table 68. Intertek Company Details
Table 69. Intertek Business Overview
Table 70. Intertek Endocrine Disruptor Assessment Product
Table 71. Intertek Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 72. Intertek Recent Development
Table 73. Smithers Company Details
Table 74. Smithers Business Overview
Table 75. Smithers Endocrine Disruptor Assessment Product
Table 76. Smithers Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 77. Smithers Recent Development
Table 78. LAUS Company Details
Table 79. LAUS Business Overview
Table 80. LAUS Endocrine Disruptor Assessment Product
Table 81. LAUS Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 82. LAUS Recent Development
Table 83. Xenometrix Company Details
Table 84. Xenometrix Business Overview
Table 85. Xenometrix Endocrine Disruptor Assessment Product
Table 86. Xenometrix Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 87. Xenometrix Recent Development
Table 88. ToxStrategies Company Details
Table 89. ToxStrategies Business Overview
Table 90. ToxStrategies Endocrine Disruptor Assessment Product
Table 91. ToxStrategies Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 92. ToxStrategies Recent Development
Table 93. Fera Science Company Details
Table 94. Fera Science Business Overview
Table 95. Fera Science Endocrine Disruptor Assessment Product
Table 96. Fera Science Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 97. Fera Science Recent Development
Table 98. Compliance Services International Company Details
Table 99. Compliance Services International Business Overview
Table 100. Compliance Services International Endocrine Disruptor Assessment Product
Table 101. Compliance Services International Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 102. Compliance Services International Recent Development
Table 103. Staphyt Company Details
Table 104. Staphyt Business Overview
Table 105. Staphyt Endocrine Disruptor Assessment Product
Table 106. Staphyt Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 107. Staphyt Recent Development
Table 108. Creative Proteomics Company Details
Table 109. Creative Proteomics Business Overview
Table 110. Creative Proteomics Endocrine Disruptor Assessment Product
Table 111. Creative Proteomics Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 112. Creative Proteomics Recent Development
Table 113. Creative Bioarray Company Details
Table 114. Creative Bioarray Business Overview
Table 115. Creative Bioarray Endocrine Disruptor Assessment Product
Table 116. Creative Bioarray Revenue in Endocrine Disruptor Assessment Business (2020-2025) & (US$ Million)
Table 117. Creative Bioarray Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Endocrine Disruptor Assessment Picture
Figure 2. Global Endocrine Disruptor Assessment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocrine Disruptor Assessment Market Share by Type: 2024 VS 2031
Figure 4. In Vitro (Cell-based) Testing Features
Figure 5. In Vivo (Animal) Testing Features
Figure 6. In Silico (Computational) Modeling Features
Figure 7. Others Features
Figure 8. Global Endocrine Disruptor Assessment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Endocrine Disruptor Assessment Market Share by Application: 2024 VS 2031
Figure 10. Environmental Monitoring Case Studies
Figure 11. Food Safety Case Studies
Figure 12. Cosmetics and Personal Care Products Case Studies
Figure 13. Public Health and Disease Prevention Case Studies
Figure 14. Others Case Studies
Figure 15. Endocrine Disruptor Assessment Report Years Considered
Figure 16. Global Endocrine Disruptor Assessment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Endocrine Disruptor Assessment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Endocrine Disruptor Assessment Market Share by Region: 2024 VS 2031
Figure 19. Global Endocrine Disruptor Assessment Market Share by Players in 2024
Figure 20. Global Endocrine Disruptor Assessment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Endocrine Disruptor Assessment Revenue in 2024
Figure 22. North America Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 24. United States Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 28. Germany Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Endocrine Disruptor Assessment Market Share by Region (2020-2031)
Figure 36. China Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 44. Mexico Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Endocrine Disruptor Assessment Market Share by Country (2020-2031)
Figure 48. Turkey Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Endocrine Disruptor Assessment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 52. Labcorp Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 53. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 54. PerkinElmer Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 55. Intertek Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 56. Smithers Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 57. LAUS Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 58. Xenometrix Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 59. ToxStrategies Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 60. Fera Science Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 61. Compliance Services International Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 62. Staphyt Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 63. Creative Proteomics Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 64. Creative Bioarray Revenue Growth Rate in Endocrine Disruptor Assessment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232